Duan et al. reported a multi-center, case-control study involving 1,659 participants to compare the clinical validity of the methylation-, mutation-, and protein-based classifiers for blood-based early detection of nine types of #cancer.
doi.org/10.1016/j.xi...
#liquidbiopsy #CellfreeDNA #medicine
doi.org/10.1016/j.xi...
#liquidbiopsy #CellfreeDNA #medicine
September 20, 2025 at 4:15 AM
Duan et al. reported a multi-center, case-control study involving 1,659 participants to compare the clinical validity of the methylation-, mutation-, and protein-based classifiers for blood-based early detection of nine types of #cancer.
doi.org/10.1016/j.xi...
#liquidbiopsy #CellfreeDNA #medicine
doi.org/10.1016/j.xi...
#liquidbiopsy #CellfreeDNA #medicine
📌 OncoTerm - Word of the Day! 👋
📌 OncoTerm - Günün Kelimesi! 👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CellFreeDNA #CirculatingTumorDNA #cfDNA #ctDNA #LiquidBiopsy #Vocabulary
📌 OncoTerm - Günün Kelimesi! 👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CellFreeDNA #CirculatingTumorDNA #cfDNA #ctDNA #LiquidBiopsy #Vocabulary
May 9, 2025 at 8:06 AM
📌 OncoTerm - Word of the Day! 👋
📌 OncoTerm - Günün Kelimesi! 👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CellFreeDNA #CirculatingTumorDNA #cfDNA #ctDNA #LiquidBiopsy #Vocabulary
📌 OncoTerm - Günün Kelimesi! 👋
Join us as we break down key terms to empower ourselves with knowledge in the fight against cancer.
#Onco404 #Cancer #Kanser #MedSky #OncSky #CellFreeDNA #CirculatingTumorDNA #cfDNA #ctDNA #LiquidBiopsy #Vocabulary
🔔For those interested in non-invasive prenatal testing (as oneself🙋🏽) don't miss Dr. Dennis Lo, pioneer in🧬 #CellFreeDNA & #NIPT and 🏆 recipient of @sriwomenshealth.bsky.social #TheMarchOfDimes prize at #SRI2025 📍Charlotte, NC🇺🇸
📅March 29
🕓8:30am
📅March 29
🕓8:30am
We’re thrilled to announce Dr. Dennis Lo, as the recipient of the March of Dimes Richard B Johnston, Jr., MD Prize!
Known as the "father of noninvasive prenatal testing," his work in fetal DNA revolutionized prenatal care. We are honored to recognize his contributions to reproductive sciences.
Known as the "father of noninvasive prenatal testing," his work in fetal DNA revolutionized prenatal care. We are honored to recognize his contributions to reproductive sciences.
February 21, 2025 at 7:16 AM
🔔For those interested in non-invasive prenatal testing (as oneself🙋🏽) don't miss Dr. Dennis Lo, pioneer in🧬 #CellFreeDNA & #NIPT and 🏆 recipient of @sriwomenshealth.bsky.social #TheMarchOfDimes prize at #SRI2025 📍Charlotte, NC🇺🇸
📅March 29
🕓8:30am
📅March 29
🕓8:30am
Great news! The recording of our webinar with Natera, Cell-free DNA testing: An alternative option to surveillance biopsy in children is live! Interested in learning more about this potentially less invasive approach? You can watch it here:
bit.ly/40ZVlmj #CellFreeDNA #Natera #PediatricHealth
bit.ly/40ZVlmj #CellFreeDNA #Natera #PediatricHealth
Cell-free DNA testing: An alternative option to surveillance biopsy in children
An overview of cell-free DNA technology and its application in pediatric heart transplantation
www.natera.com
February 13, 2025 at 1:55 AM
Great news! The recording of our webinar with Natera, Cell-free DNA testing: An alternative option to surveillance biopsy in children is live! Interested in learning more about this potentially less invasive approach? You can watch it here:
bit.ly/40ZVlmj #CellFreeDNA #Natera #PediatricHealth
bit.ly/40ZVlmj #CellFreeDNA #Natera #PediatricHealth
Next in #ISHLTJournalWatch, Alex Dragnich reviews a study from @jhlt.bsky.social—can #cellfreeDNA in #EVLP perfusate reflect #lung quality and affect the decision to use in #transplantation?
@sirusjj.bsky.social
@sirusjj.bsky.social
January 5, 2026 at 5:36 PM
Next in #ISHLTJournalWatch, Alex Dragnich reviews a study from @jhlt.bsky.social—can #cellfreeDNA in #EVLP perfusate reflect #lung quality and affect the decision to use in #transplantation?
@sirusjj.bsky.social
@sirusjj.bsky.social
A low-cost #BloodTest on a chip detects #LungCancer with over 90 percent accuracy by identifying the tumor's biological fingerprint, offering a potential complement to CT scans for monitoring #TreatmentResponse.
#CellFreeDNA #LungCancerDiagnosis #DiagnosticTest
#CellFreeDNA #LungCancerDiagnosis #DiagnosticTest
A simple, low-cost blood test on a chip diagnoses lung cancer without DNA sequencing – BioNews Central
A low-cost blood test on a chip detects lung cancer with over 90 percent accuracy by identifying the tumor's biological fingerprint, offering a potential complement to CT scans for monitoring treatment response. ...
sbee.link
August 12, 2026 at 11:36 PM
A low-cost #BloodTest on a chip detects #LungCancer with over 90 percent accuracy by identifying the tumor's biological fingerprint, offering a potential complement to CT scans for monitoring #TreatmentResponse.
#CellFreeDNA #LungCancerDiagnosis #DiagnosticTest
#CellFreeDNA #LungCancerDiagnosis #DiagnosticTest
Speaker line-up complete for Maxwell in Focus. Final speaker: Sarinder Day, North Bristol Trust - dd-cfDNA in kidney transplant monitoring.
10 speakers. Plenty of networking. Limited places available.
Last chance to register today: https://ow.ly/wBeH50YWLyO
#MaxwellInFocus #CellFreeDNA
10 speakers. Plenty of networking. Limited places available.
Last chance to register today: https://ow.ly/wBeH50YWLyO
#MaxwellInFocus #CellFreeDNA
June 5, 2026 at 8:05 AM
Speaker line-up complete for Maxwell in Focus. Final speaker: Sarinder Day, North Bristol Trust - dd-cfDNA in kidney transplant monitoring.
10 speakers. Plenty of networking. Limited places available.
Last chance to register today: https://ow.ly/wBeH50YWLyO
#MaxwellInFocus #CellFreeDNA
10 speakers. Plenty of networking. Limited places available.
Last chance to register today: https://ow.ly/wBeH50YWLyO
#MaxwellInFocus #CellFreeDNA
Maxwell in Focus is just over a week away.
Speaker spotlight: Debbie Hughes, Royal Marsden - the SMP2 project and cell-free DNA in clinical oncology.
Join us at the free event on 9 June 2026 in London.
Register at: https://ow.ly/IFRF50YWKoj
#MaxwellInFocus #CellFreeDNA
Speaker spotlight: Debbie Hughes, Royal Marsden - the SMP2 project and cell-free DNA in clinical oncology.
Join us at the free event on 9 June 2026 in London.
Register at: https://ow.ly/IFRF50YWKoj
#MaxwellInFocus #CellFreeDNA
May 28, 2026 at 11:50 AM
Maxwell in Focus is just over a week away.
Speaker spotlight: Debbie Hughes, Royal Marsden - the SMP2 project and cell-free DNA in clinical oncology.
Join us at the free event on 9 June 2026 in London.
Register at: https://ow.ly/IFRF50YWKoj
#MaxwellInFocus #CellFreeDNA
Speaker spotlight: Debbie Hughes, Royal Marsden - the SMP2 project and cell-free DNA in clinical oncology.
Join us at the free event on 9 June 2026 in London.
Register at: https://ow.ly/IFRF50YWKoj
#MaxwellInFocus #CellFreeDNA
Our Maxwell in Focus speaker series continues
Sarah Peacock, Addenbrooke's Cambridge - implementing dd-cfDNA in the clinic. Pre-analytical variables and reproducibility in transplant monitoring
Free event, 9 June 2026, London - register at https://ow.ly/J51s50YWIft
#MaxwellInFocus #CellFreeDNA
Sarah Peacock, Addenbrooke's Cambridge - implementing dd-cfDNA in the clinic. Pre-analytical variables and reproducibility in transplant monitoring
Free event, 9 June 2026, London - register at https://ow.ly/J51s50YWIft
#MaxwellInFocus #CellFreeDNA
May 18, 2026 at 11:50 AM
Our Maxwell in Focus speaker series continues
Sarah Peacock, Addenbrooke's Cambridge - implementing dd-cfDNA in the clinic. Pre-analytical variables and reproducibility in transplant monitoring
Free event, 9 June 2026, London - register at https://ow.ly/J51s50YWIft
#MaxwellInFocus #CellFreeDNA
Sarah Peacock, Addenbrooke's Cambridge - implementing dd-cfDNA in the clinic. Pre-analytical variables and reproducibility in transplant monitoring
Free event, 9 June 2026, London - register at https://ow.ly/J51s50YWIft
#MaxwellInFocus #CellFreeDNA
📚 New Review for your weekend reading!
Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA
🔓 buff.ly/4a4AmPZ
#Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA
Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA
🔓 buff.ly/4a4AmPZ
#Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA
March 26, 2026 at 9:47 AM
📚 New Review for your weekend reading!
Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA
🔓 buff.ly/4a4AmPZ
#Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA
Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA
🔓 buff.ly/4a4AmPZ
#Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA
.@chattertonzac et al. From @Sydney_Uni detected neural trauma in @USNavy personnel subjected to explosive blasts using a #cellfreeDNA methylation assay.
Also used to detect neurodegeneration. Preprint here:
https://www.biorxiv.org/content/10.1101/538827v1
Also used to detect neurodegeneration. Preprint here:
https://www.biorxiv.org/content/10.1101/538827v1
December 3, 2024 at 5:29 PM
.@chattertonzac et al. From @Sydney_Uni detected neural trauma in @USNavy personnel subjected to explosive blasts using a #cellfreeDNA methylation assay.
Also used to detect neurodegeneration. Preprint here:
https://www.biorxiv.org/content/10.1101/538827v1
Also used to detect neurodegeneration. Preprint here:
https://www.biorxiv.org/content/10.1101/538827v1
Synapse: Your Connection to our MSK Authors
Meet: Michelle Wu
Research Focus: SKI Epidemiology/Biostatistics; Senior Project Manager
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
synapse.mskcc.org/synapse/peop...
#OvarianCancer #ClonalEvolution
#CellFreeDNA
Meet: Michelle Wu
Research Focus: SKI Epidemiology/Biostatistics; Senior Project Manager
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
synapse.mskcc.org/synapse/peop...
#OvarianCancer #ClonalEvolution
#CellFreeDNA
January 22, 2026 at 3:38 PM
Synapse: Your Connection to our MSK Authors
Meet: Michelle Wu
Research Focus: SKI Epidemiology/Biostatistics; Senior Project Manager
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
synapse.mskcc.org/synapse/peop...
#OvarianCancer #ClonalEvolution
#CellFreeDNA
Meet: Michelle Wu
Research Focus: SKI Epidemiology/Biostatistics; Senior Project Manager
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
synapse.mskcc.org/synapse/peop...
#OvarianCancer #ClonalEvolution
#CellFreeDNA
🌟New Resource article
Read about the pancancer landscape of cancer-specific cell-free DNA methylation and fragmentomic features from plasma samples from 1,294 patients
✒️Yong Zeng, @matlupien.bsky.social, @pughlab.bsky.social, Housheng Hansen He & colleagues
www.nature.com/articles/s43...
Read about the pancancer landscape of cancer-specific cell-free DNA methylation and fragmentomic features from plasma samples from 1,294 patients
✒️Yong Zeng, @matlupien.bsky.social, @pughlab.bsky.social, Housheng Hansen He & colleagues
www.nature.com/articles/s43...
A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection - Nature Cancer
Zeng et al. analyzed cfDNA methylation and fragmentomic data from 1,294 patient plasma samples across 14 major cancer types to present a comprehensive landscape of pancancer and cancer-specific cell-f...
nature.com
February 24, 2026 at 4:57 PM
📈 HIGHLY CITED | Influential research attracting global attention
📌 Title: The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury
🔗 Link: www.mdpi.com/2227-9059/12...
#HighlyCited #ResearchImpact #Sepsis #AcuteKidneyInjury #Biomarkers #NGAL #CellFreeDNA
📌 Title: The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury
🔗 Link: www.mdpi.com/2227-9059/12...
#HighlyCited #ResearchImpact #Sepsis #AcuteKidneyInjury #Biomarkers #NGAL #CellFreeDNA
www.mdpi.com
June 14, 2026 at 11:49 PM
📈 HIGHLY CITED | Influential research attracting global attention
📌 Title: The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury
🔗 Link: www.mdpi.com/2227-9059/12...
#HighlyCited #ResearchImpact #Sepsis #AcuteKidneyInjury #Biomarkers #NGAL #CellFreeDNA
📌 Title: The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury
🔗 Link: www.mdpi.com/2227-9059/12...
#HighlyCited #ResearchImpact #Sepsis #AcuteKidneyInjury #Biomarkers #NGAL #CellFreeDNA
Groundbreaking study paves the way for #noninvasive #BladderCancerScreening tools that enhance patient comfort and improve outcomes.
#BladderCancer #UrineTest #CellFreeDNA
#BladderCancer #UrineTest #CellFreeDNA
A simple urine test could revolutionize bladder cancer diagnosis and treatment – BioNews Central
Groundbreaking study paves the way for noninvasive bladder cancer screening tools that enhance patient comfort and improve outcomes. ...
sbee.link
December 5, 2025 at 7:56 PM
Groundbreaking study paves the way for #noninvasive #BladderCancerScreening tools that enhance patient comfort and improve outcomes.
#BladderCancer #UrineTest #CellFreeDNA
#BladderCancer #UrineTest #CellFreeDNA
Researchers found that #BloodPlatelets absorb #CellFreeDNA (#cfDNA) from dying cells to limit harmful #inflammation and #autoimmunity, and then release that #DNA upon activation to direct targeted #InflammatoryResponses.
#Platelets
#Platelets
A critical new function of blood platelets discovered – BioNews Central
Researchers found that blood platelets absorb cell-free DNA from dying cells to limit harmful inflammation and autoimmunity, and then release that DNA upon activation to direct targeted inflammatory responses. ...
sbee.link
August 16, 2025 at 1:57 AM
Researchers found that #BloodPlatelets absorb #CellFreeDNA (#cfDNA) from dying cells to limit harmful #inflammation and #autoimmunity, and then release that #DNA upon activation to direct targeted #InflammatoryResponses.
#Platelets
#Platelets
Prenatal #CellFreeDNA screening enables the detection of early placental and endothelial-tissue aberrations and may aid in the determination of #preeclampsia risk. #EarlyDetection #MaternalHealth #GeneticTesting
http://dlvr.it/THyPrd
http://dlvr.it/THyPrd
February 13, 2025 at 4:07 PM
Prenatal #CellFreeDNA screening enables the detection of early placental and endothelial-tissue aberrations and may aid in the determination of #preeclampsia risk. #EarlyDetection #MaternalHealth #GeneticTesting
http://dlvr.it/THyPrd
http://dlvr.it/THyPrd